VIST vs. RIGL
VIST (Vista Oil & Gas, S.A.B. de C.V.) and RIGL (Rigel Pharmaceuticals, Inc.) are both stocks. VIST operates in Oil & Gas E&P (Energy), while RIGL operates in Biotechnology (Healthcare). Over the past 5 years, VIST returned 80.45%/yr vs -3.96%/yr for RIGL. At a 0.09 correlation, their price movements are largely independent.
Performance
VIST vs. RIGL - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, VIST achieves a 48.25% return, which is significantly higher than RIGL's -23.30% return.
VIST
- 1D
- -1.21%
- 1M
- 5.47%
- YTD
- 48.25%
- 6M
- 45.86%
- 1Y
- 37.65%
- 3Y*
- 48.18%
- 5Y*
- 80.45%
- 10Y*
- —
RIGL
- 1D
- 2.40%
- 1M
- 2.24%
- YTD
- -23.30%
- 6M
- -19.45%
- 1Y
- 54.23%
- 3Y*
- 27.10%
- 5Y*
- -3.96%
- 10Y*
- 3.28%
VIST vs. RIGL - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|---|
VIST Vista Oil & Gas, S.A.B. de C.V. | 48.25% | -10.07% | 83.36% | 88.44% | 193.81% | 108.20% | -67.39% | -4.85% |
RIGL Rigel Pharmaceuticals, Inc. | -23.30% | 154.64% | 16.00% | -3.33% | -43.40% | -24.29% | 63.55% | -6.55% |
Correlation
The correlation between VIST and RIGL is -0.17, meaning they tend to move in opposite directions. This is especially valuable for risk management - when one declines, the other has historically tended to hold steady or rise.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | -0.17 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.03 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.05 |
Correlation (All Time) Calculated using the full available price history since Jul 26, 2019 | 0.09 |
The correlation between VIST and RIGL shifts across timeframes, from -0.17 (1 year) to 0.09 (all time), reflecting how their relationship changes across market environments.
Fundamentals
VIST:
$7.95B
RIGL:
$646.69M
VIST:
$6.82
RIGL:
$19.21
VIST:
10.58
RIGL:
1.71
VIST:
0.08
RIGL:
0.00
VIST:
2.71
RIGL:
2.08
VIST:
3.06
RIGL:
1.62
VIST:
$2.90B
RIGL:
$299.77M
VIST:
$1.31B
RIGL:
$279.95M
VIST:
$2.12B
RIGL:
$125.80M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
VIST vs. RIGL — Risk / Return Rank
VIST
RIGL
VIST vs. RIGL - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Vista Oil & Gas, S.A.B. de C.V. (VIST) and Rigel Pharmaceuticals, Inc. (RIGL). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| VIST | RIGL | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.02 | ||
| Sortino ratioReturn per unit of downside risk | -0.23 | ||
| Omega ratioGain probability vs. loss probability | 1.17 | 1.20 | -0.04 |
| Calmar ratioReturn relative to maximum drawdown | 1.04 | 1.09 | -0.05 |
| Martin ratioReturn relative to average drawdown | 2.36 | 1.91 | +0.45 |
Loading charts...
Drawdowns
VIST vs. RIGL - Drawdown Comparison
The maximum VIST drawdown since its inception was -81.19%, smaller than the maximum RIGL drawdown of -99.37%. Use the drawdown chart below to compare losses from any high point for VIST and RIGL.
Loading charts...
Drawdown Indicators
| VIST | RIGL | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -81.19% | -99.37% | +18.18% |
Max Drawdown (1Y)Largest decline over 1 year | -36.48% | -50.08% | +13.60% |
Max Drawdown (3Y)Largest decline over 3 years | -43.36% | -57.75% | +14.39% |
Max Drawdown (5Y)Largest decline over 5 years | -43.36% | -85.24% | +41.88% |
Max Drawdown (10Y)Largest decline over 10 years | — | -86.40% | — |
Current DrawdownCurrent decline from peak | -8.97% | -96.93% | +87.96% |
Average DrawdownAverage peak-to-trough decline | -28.22% | -90.91% | +62.69% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 16.01% | 28.64% | -12.63% |
Volatility
VIST vs. RIGL - Volatility Comparison
Vista Oil & Gas, S.A.B. de C.V. (VIST) has a higher volatility of 12.74% compared to Rigel Pharmaceuticals, Inc. (RIGL) at 12.05%. This indicates that VIST's price experiences larger fluctuations and is considered to be riskier than RIGL based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| VIST | RIGL | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 12.74% | 12.05% | +0.69% |
Volatility (6M)Calculated over the trailing 6-month period | 32.81% | 36.64% | -3.83% |
Volatility (1Y)Calculated over the trailing 1-year period | 49.68% | 69.89% | -20.21% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 52.00% | 85.46% | -33.46% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 61.12% | 82.81% | -21.69% |
Dividends
VIST vs. RIGL - Dividend Comparison
Neither VIST nor RIGL has paid dividends to shareholders.
Financials
VIST vs. RIGL - Financials Comparison
This section allows you to compare key financial metrics between Vista Oil & Gas, S.A.B. de C.V. and Rigel Pharmaceuticals, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
VIST vs. RIGL - Profitability Comparison
VIST - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Vista Oil & Gas, S.A.B. de C.V. reported a gross profit of 472.36M and revenue of 865.01M. Therefore, the gross margin over that period was 54.6%.
RIGL - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Rigel Pharmaceuticals, Inc. reported a gross profit of 54.21M and revenue of 58.82M. Therefore, the gross margin over that period was 92.2%.
VIST - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Vista Oil & Gas, S.A.B. de C.V. reported an operating income of 216.12M and revenue of 865.01M, resulting in an operating margin of 25.0%.
RIGL - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Rigel Pharmaceuticals, Inc. reported an operating income of 11.89M and revenue of 58.82M, resulting in an operating margin of 20.2%.
VIST - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Vista Oil & Gas, S.A.B. de C.V. reported a net income of 107.71M and revenue of 865.01M, resulting in a net margin of 12.5%.
RIGL - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Rigel Pharmaceuticals, Inc. reported a net income of 8.65M and revenue of 58.82M, resulting in a net margin of 14.7%.
Frequently Asked Questions
VIST and RIGL have a correlation of -0.17, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
VIST has higher volatility (12.74%) compared to RIGL (12.05%). In terms of maximum drawdown, VIST dropped -81.19% vs RIGL's -99.37%.
RIGL currently has the higher Sharpe Ratio (0.78 vs 0.76), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for VIST and RIGL
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer